Puerarin‑Loaded pH‑Responsive ZIF‑90 Nanoparticles Ameliorate Osteoporosis via Enhancing H3K18 Lactylation and Suppressing Aberrant Osteoclast Activation
Advanced Science · 2026-09-27
DOI: 10.1002/advs.77869 ↗At a glance
Journal article in Advanced Science, published online on 2026-09-27. Written by Jiajia Lu and 5 co-authors. Institution: Department of Orthopedic Trauma, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, People's Republic of China. Cited 1 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, "Medicine +X" interdisciplinary research program of Tongji University, Clinical Key Specialty Construction Project of Hongkou District Health Commission.
Abstract (original language)
Osteoporosis is characterized by dysregulated osteoclast activity, leading to excessive bone resorption and structural damage. In this study, we developed pH‐responsive ZIF‐90 nanoparticles loaded with puerarin (PU) (ZIF‐90@PU) for microenvironment‐responsive osteoporosis therapy through epigenetic modulation. Following self‐assembly, the nanoparticles underwent dynamic light scattering (DLS), field emission scanning electron microscopy (FE‐SEM), powder X‐ray diffraction (PXRD), Fourier‐transform infrared spectroscopy (FTIR), and X‐ray photoelectron spectroscopy (XPS); these analyses verified efficient puerarin encapsulation and pH‐triggered release. In cell‐based experiments, ZIF‐90@PU suppressed the differentiation of bone marrow‐derived macrophages (BMMs) into osteoclasts while promoting osteogenic differentiation of bone marrow‐derived mesenchymal stem cells (BMSCs). Administration of ZIF‐90@PU to ovariectomized (OVX) mice produced significant gains in bone mineral density, trabecular architecture, and bone strength without detectable toxicity. Mechanistically, ZIF‐90@PU treatment was associated with increased H3K18 lactylation and reduced NFATc1 signaling, accompanied by suppression of osteoclast activation. This study introduces ZIF‐90@PU as a novel epigenetic‐modulating nanomedicine for osteoporosis treatment.
Subjects
Author keywords
Authors and institutions
- Department of Orthopedic Trauma, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, People's Republic of China.
- Department of Orthopedic Trauma, Haimen People's Hospital of Jiangsu Province, Haimen, People's Republic of China.
- Department of Orthopedic, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, Shanghai, People's Republic of China.
ORCID profiles: Jiajia Lu, Xiaojian Shi
Funding
- National Natural Science Foundation of China
- "Medicine +X" interdisciplinary research program of Tongji University
- Clinical Key Specialty Construction Project of Hongkou District Health Commission
- Mandatory project of Nantong Health Commission
- Scientific Research Project of Jiangsu Geriatrics Society
Cite
APA
Lu, J., Xi, Y., Wang, S., Chen, Y., Yang, J., & Shi, X. (2026). Puerarin‑Loaded pH‑Responsive ZIF‑90 Nanoparticles Ameliorate Osteoporosis via Enhancing H3K18 Lactylation and Suppressing Aberrant Osteoclast Activation. Advanced Science. https://doi.org/10.1002/advs.77869
Vancouver
Lu J, Xi Y, Wang S, Chen Y, Yang J, Shi X. Puerarin‑Loaded pH‑Responsive ZIF‑90 Nanoparticles Ameliorate Osteoporosis via Enhancing H3K18 Lactylation and Suppressing Aberrant Osteoclast Activation. Advanced Science. 2026. doi:10.1002/advs.77869
BibTeX
@article{Lu2026,
author = {Lu, Jiajia and Xi, Yue and Wang, Sheng and Chen, Ye and Yang, Jiajie and Shi, Xiaojian},
title = {Puerarin‑Loaded pH‑Responsive ZIF‑90 Nanoparticles Ameliorate Osteoporosis via Enhancing H3K18 Lactylation and Suppressing Aberrant Osteoclast Activation},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.77869}
}
EUVIMED